Brandon Couillard
Stock Analyst at Wells Fargo
(4.87)
# 330
Out of 4,456 analysts
686
Total ratings
62%
Success rate
17.8%
Average return
Main Sectors:
Stocks Rated by Brandon Couillard
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TECH Bio-Techne | Maintained: Buy | $62 | $71.00 | -12.68% | 6 | Jun 26, 2026 | |
| GH Guardant Health | Maintained: Buy | $125 | $149.22 | -16.23% | 7 | Jun 17, 2026 | |
| A Agilent Technologies | Maintained: Buy | $165 → $160 | $136.01 | +17.64% | 55 | May 28, 2026 | |
| MLAB Mesa Laboratories | Rated: Hold | $94 | $102.42 | -8.22% | 14 | May 28, 2026 | |
| BIO Bio-Rad Laboratories | Maintained: Hold | $290 → $310 | $300.79 | +3.06% | 56 | May 22, 2026 | |
| BLLN BillionToOne | Maintained: Hold | $90 | $118.17 | -23.84% | 4 | May 22, 2026 | |
| TMO Thermo Fisher Scientific | Rated: Buy | $615 | $513.03 | +19.88% | 40 | May 21, 2026 | |
| WAT Waters | Maintained: Hold | $355 → $370 | $374.41 | -1.18% | 29 | May 14, 2026 | |
| NTRA Natera | Maintained: Hold | $215 → $220 | $261.91 | -16.00% | 4 | May 8, 2026 | |
| MYGN Myriad Genetics | Maintained: Hold | $6 → $5.5 | $5.88 | -6.46% | 29 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $155 → $75 | $69.82 | +7.42% | 13 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $240 → $212 | $196.19 | +8.06% | 52 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $190 → $180 | $147.01 | +22.44% | 29 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $18 → $21 | $28.82 | -27.13% | 11 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 → $14 | $10.28 | +36.19% | 18 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $107 → $110 | $113.02 | -2.67% | 38 | Feb 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $50 → $55 | $60.91 | -9.70% | 40 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1,400 → $1,450 | $1,263.75 | +14.74% | 25 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 → $4.5 | $6.22 | -27.65% | 12 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 → $17 | $16.00 | n/a | 4 | Mar 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $88 → $81 | $84.95 | n/a | 21 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $36 → $38 | $11.01 | n/a | 25 | Feb 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $32 → $23 | $26.96 | n/a | 6 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $305 → $325 | $178.43 | n/a | 43 | Feb 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $200 | $328.66 | n/a | 26 | Aug 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 → $11 | $2.00 | n/a | 2 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $26 | $2.39 | n/a | 7 | Jun 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $16 → $15 | $4.46 | n/a | 20 | Aug 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $280 → $300 | $155.92 | n/a | 17 | May 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3.5 → $4.5 | $1.53 | n/a | 16 | Aug 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2 → $1.75 | $1.03 | n/a | 11 | Jul 27, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $116 | $59.00 | n/a | 1 | May 31, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $26 | $39.41 | n/a | 5 | Nov 22, 2016 |
Bio-Techne
Jun 26, 2026
Maintained: Buy
Price Target: $62
Current: $71.00
Upside: -12.68%
Guardant Health
Jun 17, 2026
Maintained: Buy
Price Target: $125
Current: $149.22
Upside: -16.23%
Agilent Technologies
May 28, 2026
Maintained: Buy
Price Target: $165 → $160
Current: $136.01
Upside: +17.64%
Mesa Laboratories
May 28, 2026
Rated: Hold
Price Target: $94
Current: $102.42
Upside: -8.22%
Bio-Rad Laboratories
May 22, 2026
Maintained: Hold
Price Target: $290 → $310
Current: $300.79
Upside: +3.06%
BillionToOne
May 22, 2026
Maintained: Hold
Price Target: $90
Current: $118.17
Upside: -23.84%
Thermo Fisher Scientific
May 21, 2026
Rated: Buy
Price Target: $615
Current: $513.03
Upside: +19.88%
Waters
May 14, 2026
Maintained: Hold
Price Target: $355 → $370
Current: $374.41
Upside: -1.18%
Natera
May 8, 2026
Maintained: Hold
Price Target: $215 → $220
Current: $261.91
Upside: -16.00%
Myriad Genetics
May 6, 2026
Maintained: Hold
Price Target: $6 → $5.5
Current: $5.88
Upside: -6.46%
May 5, 2026
Rated: Buy
Price Target: $155 → $75
Current: $69.82
Upside: +7.42%
Apr 22, 2026
Rated: Hold
Price Target: $240 → $212
Current: $196.19
Upside: +8.06%
Feb 25, 2026
Maintained: Buy
Price Target: $190 → $180
Current: $147.01
Upside: +22.44%
Feb 25, 2026
Maintained: Hold
Price Target: $18 → $21
Current: $28.82
Upside: -27.13%
Feb 13, 2026
Maintained: Buy
Price Target: $16 → $14
Current: $10.28
Upside: +36.19%
Feb 3, 2026
Maintained: Hold
Price Target: $107 → $110
Current: $113.02
Upside: -2.67%
Dec 15, 2025
Maintained: Buy
Price Target: $50 → $55
Current: $60.91
Upside: -9.70%
Dec 15, 2025
Maintained: Hold
Price Target: $1,400 → $1,450
Current: $1,263.75
Upside: +14.74%
Dec 15, 2025
Maintained: Buy
Price Target: $4 → $4.5
Current: $6.22
Upside: -27.65%
Mar 13, 2024
Maintained: Buy
Price Target: $21 → $17
Current: $16.00
Upside: n/a
Mar 6, 2024
Maintained: Hold
Price Target: $88 → $81
Current: $84.95
Upside: n/a
Feb 29, 2024
Maintained: Buy
Price Target: $36 → $38
Current: $11.01
Upside: n/a
Feb 9, 2024
Downgraded: Hold
Price Target: $32 → $23
Current: $26.96
Upside: n/a
Feb 1, 2024
Maintained: Buy
Price Target: $305 → $325
Current: $178.43
Upside: n/a
Aug 29, 2022
Maintained: Buy
Price Target: $200
Current: $328.66
Upside: n/a
May 4, 2022
Maintained: Buy
Price Target: $13 → $11
Current: $2.00
Upside: n/a
Jun 18, 2021
Rated: Buy
Price Target: $26
Current: $2.39
Upside: n/a
Aug 6, 2020
Rated: Hold
Price Target: $16 → $15
Current: $4.46
Upside: n/a
May 18, 2020
Maintained: Buy
Price Target: $280 → $300
Current: $155.92
Upside: n/a
Aug 8, 2018
Reiterated: Hold
Price Target: $3.5 → $4.5
Current: $1.53
Upside: n/a
Jul 27, 2018
Reiterated: Buy
Price Target: $2 → $1.75
Current: $1.03
Upside: n/a
May 31, 2017
Reiterated: Buy
Price Target: $116
Current: $59.00
Upside: n/a
Nov 22, 2016
Reiterated: Hold
Price Target: $26
Current: $39.41
Upside: n/a